Sign in or create an account to add this stock to your watchlist.
About NanoString Technologies (NASDAQ:NSTG)
NanoString Technologies, Inc. provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; and Pan Cancer and 360 gene expression, protein immune profiling, neuropathology and neuro-inflammation gene expression, autoimmune disease gene expression, nCounter Vantage 3D, miRNA expression, cancer copy number variation, and other gene expression panels. Further, the company offers nCounter-based reagents that allow users to design customized assays; Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and nCounter Dx Analysis System and Prosigna molecular diagnostic test kits. It has collaboration with Celgene Corporation; Merck & Co., Inc.; Medivation, Inc.; and Astellas Pharma, Inc. The company was founded in 2003 and is headquartered in Seattle, Washington.
Industry, Sector and Symbol
Industry Biological products, except diagnostic
Trailing P/E Ratio-6.90
Forward P/E Ratio-4.55
Sales & Book Value
Annual Sales$114.90 million
Price / Sales2.85
Price / CashN/A
Book Value$0.97 per share
Price / Book13.09
EPS (Most Recent Fiscal Year)($1.84)
Return on Equity-108.29%
Return on Assets-31.72%
NanoString Technologies (NASDAQ:NSTG) Frequently Asked Questions
What is NanoString Technologies' stock symbol?
NanoString Technologies trades on the NASDAQ under the ticker symbol "NSTG."
How were NanoString Technologies' earnings last quarter?
NanoString Technologies Inc (NASDAQ:NSTG) issued its earnings results on Tuesday, May, 8th. The biotechnology company reported ($0.75) earnings per share for the quarter, topping analysts' consensus estimates of ($0.76) by $0.01. The biotechnology company earned $23.09 million during the quarter, compared to analyst estimates of $21.48 million. NanoString Technologies had a negative net margin of 36.62% and a negative return on equity of 108.29%. View NanoString Technologies' Earnings History.
When is NanoString Technologies' next earnings date?
What guidance has NanoString Technologies issued on next quarter's earnings?
NanoString Technologies issued an update on its FY18 earnings guidance on Wednesday, March, 7th. The company provided EPS guidance of (2.90)-($2.60) for the period, compared to the Thomson Reuters consensus estimate of ($2.48).
What price target have analysts set for NSTG?
4 brokers have issued 12-month price objectives for NanoString Technologies' shares. Their forecasts range from $12.00 to $20.00. On average, they anticipate NanoString Technologies' share price to reach $14.6667 in the next twelve months. View Analyst Ratings for NanoString Technologies.
Who are some of NanoString Technologies' key competitors?
Some companies that are related to NanoString Technologies include Cellectis (CLLS), Adaptimmune Therapeutics (ADAP), Acorda Therapeutics (ACOR), Bavarian Nordic (BVNRY), Coherus BioSciences (CHRS), La Jolla Pharmaceutical (LJPC), Heska (HSKA), Solid Biosciences (SLDB), Novavax (NVAX), Voyager Therapeutics (VYGR), Fate Therapeutics (FATE), CASI Pharmaceuticals (CASI), BioCryst Pharmaceuticals (BCRX), Mesoblast (MESO) and Vericel (VCEL).
Who are NanoString Technologies' key executives?
NanoString Technologies' management team includes the folowing people:
- Mr. R. Bradley Gray, CEO, Pres & Director (Age 41)
- Mr. David W. Ghesquiere, Sr. VP of Corp. & Bus. Devel. (Age 51)
- Mr. K. Thomas Bailey, CFO & Treasurer (Age 49)
- Dr. Mary Tedd Allen, Sr. VP of Operations (Age 55)
- Mr. Douglas S. Farrell, VP of Investor Relations & Corp. Communications
Has NanoString Technologies been receiving favorable news coverage?
News headlines about NSTG stock have trended somewhat positive this week, Accern Sentiment reports. The research group identifies negative and positive media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. NanoString Technologies earned a daily sentiment score of 0.09 on Accern's scale. They also gave press coverage about the biotechnology company an impact score of 47.30 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.
Who are NanoString Technologies' major shareholders?
NanoString Technologies' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.94%), Neuberger Berman Group LLC (3.99%), Millennium Management LLC (3.32%), Altrinsic Global Advisors LLC (2.04%), Northern Trust Corp (0.94%) and Algert Global LLC (0.80%). Company insiders that own NanoString Technologies stock include Barney Saunders, Charles P Waite Jr, David W Ghesquiere, James A Johnson, R Bradley Gray, Wayne Burns and William Young. View Institutional Ownership Trends for NanoString Technologies.
Which institutional investors are selling NanoString Technologies stock?
NSTG stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Millennium Management LLC, Spark Investment Management LLC, Wells Fargo & Company MN, Neuberger Berman Group LLC, Northern Trust Corp and Lakeview Capital Partners LLC. View Insider Buying and Selling for NanoString Technologies.
Which institutional investors are buying NanoString Technologies stock?
NSTG stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., JPMorgan Chase & Co., Algert Global LLC, Platinum Investment Management Ltd., Citadel Advisors LLC, Altrinsic Global Advisors LLC and Baird Financial Group Inc.. View Insider Buying and Selling for NanoString Technologies.
How do I buy shares of NanoString Technologies?
Shares of NSTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is NanoString Technologies' stock price today?
One share of NSTG stock can currently be purchased for approximately $12.70.
How big of a company is NanoString Technologies?
NanoString Technologies has a market capitalization of $321.89 million and generates $114.90 million in revenue each year. The biotechnology company earns $-43,560,000.00 in net income (profit) each year or ($1.84) on an earnings per share basis. NanoString Technologies employs 467 workers across the globe.
How can I contact NanoString Technologies?
NanoString Technologies' mailing address is 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109. The biotechnology company can be reached via phone at 206-378-6266 or via email at investorrela[email protected]
MarketBeat Community Rating for NanoString Technologies (NSTG)MarketBeat's community ratings are surveys of what our community members think about NanoString Technologies and other stocks. Vote "Outperform" if you believe NSTG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NSTG will underperform the S&P 500 over the long term. You may vote once every thirty days.
NanoString Technologies (NASDAQ:NSTG) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
NanoString Technologies (NASDAQ NSTG) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 20.90%
Institutional Ownership Percentage: 90.00%
NanoString Technologies (NASDAQ NSTG) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|3/13/2018||William Young||Director||Buy||30,000||$6.91||$207,300.00||30,000|| |
|11/13/2017||David W Ghesquiere||SVP||Sell||689||$8.14||$5,608.46||17,327|| |
|4/3/2017||R Bradley Gray||Insider||Sell||1,100||$20.58||$22,638.00||75,785|| |
|12/6/2016||Wayne Burns||SVP||Sell||21,666||$22.04||$477,518.64||71,034|| |
|11/21/2016||Charles P Waite Jr||Director||Sell||588,024||$21.25||$12,495,510.00||1,707|| |
|11/11/2016||Barney Saunders||SVP||Sell||11,983||$22.48||$269,377.84||6,371|| |
|11/11/2016||James A Johnson||CFO||Sell||10,000||$22.57||$225,700.00||10,698|| |
|11/11/2016||R Bradley Gray||Insider||Sell||37,325||$22.49||$839,439.25||79,428|| |
|10/26/2016||Charles P Waite Jr||Director||Sell||42,489||$20.56||$873,573.84||1,707|| |
|9/8/2016||Charles P Waite Jr||Director||Sell||29,105||$16.51||$480,523.55||1,707|| |
|9/7/2016||Wayne Burns||SVP||Sell||3,961||$16.50||$65,356.50||59,704|| |
|8/30/2016||Charles P Waite Jr||Director||Sell||111,060||$16.57||$1,840,264.20||1,707|| |
|8/25/2016||Charles P Waite Jr||Director||Sell||40,363||$16.59||$669,622.17||1,707|| |
|8/22/2016||Charles P Waite Jr||Director||Sell||72,145||$16.61||$1,198,328.45||1,707|| |
|8/16/2016||Charles P Waite Jr||Director||Sell||257,698||$16.55||$4,264,901.90||1,707|| |
|3/2/2016||David W Ghesquiere||SVP||Sell||1,321||$14.86||$19,630.06||2,521|| |
|8/13/2015||Wayne Burns||SVP||Sell||30,000||$14.93||$447,900.00|| |
|12/2/2014||Barney Saunders||SVP||Sell||30,000||$14.93||$447,900.00|| |
|11/14/2014||Charles P Waite Jr||Director||Sell||14,632||$12.25||$179,242.00|| |
|9/8/2014||Charles P Waite Jr||Director||Sell||45,000||$11.21||$504,450.00|| |
|9/5/2014||Charles P Waite Jr||Director||Sell||86,942||$11.17||$971,142.14|| |
|9/3/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||35,000||$11.15||$390,250.00|| |
|8/19/2014||Charles P Waite Jr||Director||Sell||1,700||$12.01||$20,417.00|| |
|8/19/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||20,257||$12.05||$244,096.85|| |
|8/18/2014||Charles P Waite Jr||Director||Sell||18,557||$12.05||$223,611.85|| |
|8/18/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||11,925||$12.05||$143,696.25|| |
|8/15/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||28,801||$12.36||$355,980.36|| |
|6/13/2014||Charles P Waite Jr||Director||Sell||166,755||$15.08||$2,514,665.40|| |
|6/13/2014||Wayne Burns||SVP||Sell||4,900||$15.01||$73,549.00|| |
|6/12/2014||Barney Saunders||SVP||Sell||28,000||$15.04||$421,120.00|| |
|6/10/2014||Ovp Venture Partners Vi Lp||Major Shareholder||Sell||160,000||$15.48||$2,476,800.00|| |
|6/9/2014||Wayne Burns||SVP||Sell||20,100||$15.76||$316,776.00|| |
|7/1/2013||Lifesciences Ii L.P. Clarus||Major Shareholder||Buy||750,000||$10.00||$7,500,000.00|| |
NanoString Technologies (NASDAQ NSTG) News Headlines
NanoString Technologies (NASDAQ:NSTG) SEC Filings
This page is loading this company's SEC Filings. Please wait...
NanoString Technologies (NASDAQ:NSTG) Income Statement, Balance Sheet and Cash Flow Statement
NanoString Technologies (NASDAQ NSTG) Stock Chart for Saturday, May, 26, 2018